More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory ...

Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...

University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined ...

Metastatic melanoma cells that have spread to lymph nodes survive by relying on a protein called ferroptosis suppressor ...

AI and virtual care revolutionize dermatology, enhancing melanoma detection, expanding patient access and improving ...

Kelly Casaccio and her sister, Laura Kosmorsky, would do just about anything for their mom, even start a business.

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...

Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...

A gene mutation known to develop into one of Queensland’s deadliest cancers could be hiding in skin undetected.

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...